MedTrace Logo

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

NCT02295969 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 307

Last updated 2017-07-26

No results posted yet for this study

Summary

Safety and tolerability of ORALAIR in children 5 to 9 years of age during the first 30 days of treatment.

Conditions

  • Allergy

Interventions

DRUG

Oralair

Observational study, Oralair is used as prescribed by the prescriber phycisian.

Sponsors & Collaborators

  • Venn Life Sciences

    collaborator OTHER

  • Stallergenes Greer

    lead INDUSTRY

Eligibility

Min Age
5 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2017-07-03
Completion
2017-07-03

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02295969 on ClinicalTrials.gov